Fingolimod Accord, caps 0.5 mg , blist 98 pce
7680683770037
CH-68377
L04AE01
Reimbursement limitations:
GILENYA3
Traitement de la sclérose en plaques (SEP) récurrente-rémittente chez l’adulte. Première prescription par un neurologue.
1 / 3
google
Details
- Product number
- -
- CPT
- -
- Packaging group
- -
- Unit
- -
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
0.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Accord Healthcare AG
4103 Bottmingen
Authorization information
- Swissmedic authorization number
- 68377
- Drug name
- Fingolimod Accord, Hartkapseln
- Galenic form
- KAHA
- ATC Code
- L04AE01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 22/11/2021
- Authorization expiration date
- 21/11/2026
- IT number
- 01.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- FINGOLIMOD Accord caps 0.5 mg 98 pce
- Description (DE)
- FINGOLIMOD Accord Kaps 0.5 mg 98 Stk
- Narcotic (BTM)
- No